|
Jul 2
|
PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine
|
|
Jan 3
|
PharmaTher Announces Grant of Stock Options
|
|
May 10
|
PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine
|
|
Jan 14
|
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
|
|
Jan 10
|
PharmaTher Provides Update for Expected FDA Approval of Ketamine
|
|
Jun 27
|
PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA
|